Talking, Testing, Tepezza: Preparing Patients for TED Treatment

Gain a comprehensive understanding of advancements in artificial intelligence (AI) algorithms for diabetic retinopathy and age-related macular degeneration (AMD).

The management paradigm for Demodex blepharitis has shifted dramatically since the FDA approval of XDEMVY (lotilaner 0.25% ophthalmic solution). This guide provides an overview of the condition and a deep dive into this unique treatment modality.

Disclosure: Drs. Zhu and Dierker are paid consultants of Tarsus.

Join Preeya K. Gupta, MD, and Madhura Tamhankar, MD, to review how ophthalmologists can discuss thyroid eye disease (TED) and TEPEZZA with patients.

Review how ophthalmologists can collaboratively manage pediatric uveitis to quickly diagnose and treat this rare inflammatory condition.

As the year comes to a close, we are taking a look back at some of the most important innovations, relevant trends, and compelling content.

Gain a comprehensive understanding of advancements in artificial intelligence (AI) algorithms for diabetic retinopathy and age-related macular degeneration (AMD).

In this session from Eyes On 2025, Matthew Bernier, Product Director at Rectangle Health, discusses what eyecare practices stand to gain by investing in technologies to speed up their insurance payments.

Learn how transitioning to electronic health records (EHRs) can affect your environmental impact and four ways eyecare professionals can do so sustainably.

Review how optometrists can get dry eye medications approved and paid for with prior authorizations, correct coding, and patient assistance programs (PAPs).